Download Free Sample Report

Milbemycin Oxime API Market, Global Outlook and Forecast 2025-2032

Milbemycin Oxime API Market, Global Outlook and Forecast 2025-2032

  • Published on : 06 February 2025
  • Pages :115
  • Report Code:SMR-8029488

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Report Overview

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl